FDA Explains Rejection Of MDMA Therapy For Treating PTSD
By Sam Reisman · September 5, 2025, 6:54 PM EDT
The U.S. Food and Drug Administration rejected a historic new drug application to treat post-traumatic stress disorder with the psychedelic MDMA due to concerns with the drug's safety and effectiveness and with...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login